Home › Blood Cancers › Kansas › Overland Park
Blood Cancers clinical trials in Overland Park, KS
3 studies for Blood Cancers are looking for participants at sites in and around Overland Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · 3 mi away
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Kansas, Fairway · 3 mi away
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- The University of Kansas Medical Center Research Institute, Fairway · 3 mi away
Blood Cancers trials in other cities
- Houston, TX46 studies
- Boston, MA28 studies
- New York City, NY26 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA18 studies
- Durham, NC16 studies
- Chicago, IL16 studies
- Edison, NJ14 studies
- Columbus, OH14 studies
- Philadelphia, PA14 studies
Other studies in Overland Park
- Non-Small Cell Lung Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Lung Cancer11 studies
- Breast Cancer10 studies
- Obesity8 studies
- Overweight7 studies
- Colorectal Cancer7 studies
- Ovarian Cancer6 studies
- Prostate Cancer6 studies
- Melanoma6 studies
- Pancreatic Cancer5 studies
- Metastatic Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.